1
Preparation of rh-Insulin National Reference standard
National Institute of BiologicalsNoida E-mail: [email protected]
Meeting of the Manufacturer’sMarch 20, 2009
2
WHY the need
╩ There is no National Reference Standard available in our country on rh-Insulin with any metrological trace ability as per ISO guidelines –17511.
╩ The certificate of Analysis also varies from one Manufacturer to another as there are no guidelines and Recommendations laid down for National Reference standard of rh-Insulin incorporated in “ Indian Pharmacopoeia”
╩ International biological standards are the “Primary standards” against which Secondary standards are calibrated. Secondary standards may be -
a) National standard , b) Regional standard, c) Working Reference material .
rh-Insulin Reference Standard
3
International conventional reference measurement procedure by International Scientific organization, WHO aInternational conventional reference measurement procedure by International Scientific organization, WHO a
International conventional Calibrator bInternational conventional Calibrator b
Manufacturer’s Working calibrator dManufacturer’s Working calibrator d
Manufacturer’s Product calibrator fManufacturer’s Product calibrator f
Manufacturer’s selected measurement procedure c
Manufacturer’s selected measurement procedure c
Manufacturer’s standing measurement procedure e
Manufacturer’s standing measurement procedure e
METROLOGICAL
TRACEABILITY
International scientific organization: WHO, NIBSC, USP
End User’s routine measurement procedure g
End User’s routine measurement procedure g
Routine Sample h Routine Sample h
RESULT i RESULT i
Manufacturer Or end user
End user
End user
CALIBRATION HIERARCHY & METROLOGICAL TRACEABILITY
MATERIAL CALIBRATION VALUE ASSIGNMENT PROCEDURE IMPLEMENTATION
Source ISO 17511-2003, First edition , 2003-08-15
4
Memorandum of Understanding
╩ All the information of API-bulk material supplied during the study will be treated as confidential and proprietary to the manufacturer’s.
╩ A MoU will be developed between
a) NIB ,
b) Industry and
c) IPC
╩ All persons involved herein by signing the agreement confirms that there is no financial or vested commercial interest.
5
Collaborators in the StudyCollaborating lab Name Study
Investigator
Pharmacopoeia Indian Pharmacopoeia Commission To Propose
Government
1.National Institute of Biologicals-NCL
2. Office of DCG(I)- NRA
3. CDSCO-zone wise-do-
Industry
rh-Insulin Manufacturer’s:
1. Biocon Bangalore
2. Wockhardt Aurangabad
3. MJ Biopharm Navi Mumbai
4. Cipla Goa
5. Eli-Lily Gurgaon
6. Aventis Mumbai
7. Novo Nordisk Denmark & Bangalore
-do-
Other Standard setting organization
1. European Pharmacopoeia
2. Japanese Pharmacopoeia
3. US Pharmacopoeia
4. WHO
5. NIST-USA
6. REMCO ( Ref material committee of ISO )
To maintain continuous
contacts
Academia To be Proposed To Propose
6
Steps in establishing National Reference standard
1. Incorporation of human Insulin National Reference Standard in IP-Monograph for Human Insulin
2. Provide collaborators with set of necessary documents
3. Establish –3.1 Inter laboratory” collaborative study for selecting a
Candidate RS material
3.2 coded material to be distributed maintaining confidentiality
33 Proficiency testing program based on NABL 162 guidelines
7
1. Quantitative uses in assays of rh-insulin bulk & formulation, either by:
╔ Biological methods╔ Physiochemical method-HPLC
2. Quantitative uses in Limit tests by Physiochemical method-HPLC
3. Qualitative uses in Identification tests, system suitability tests, chromatographic peak markers
4. Method development , evaluation of method performance
Intended Use
8
Goals of Collaborative study
Selection of rh-insulin Candidate material
Obtain API-Bulk material from a major manufacturer of rh-insulin
Detailed rh-insulin testing Protocol to include elements of :╩ Type of tests ╩ No of tests ╩ No of collaborators ╩ Elements of validation ╩ No. of replicates ╩ References to the procedure to be used.╩ Data recording forms for result compilation
Material is Calibrated and Characterized, with regular use of CRM
Statistical control in design and Analysis of Results
Assign Property values and Uncertainties
9
Assignment of Property Values
and Their Uncertainties
╔ Investigation of statistical outliers and/or use of robust statistic
╔ Methods used to assign uncertainties to property values
╔ Acquire time-zero information for future continued-suitability for use of rh-insulin Reference standard
╔ 1 Unit of Human insulin =0.0347 mg by definition (28.8 IU/mg).
╔ Value is assigned to rh-insulin bulk in IP.
╔ Need to Work Out : Assignment of Property Value to serve as Standard for Assay of 40 IU and 100 IU Insulin preparations.
10
Calibration test as per requirements of IP-2007 & USP
Characterization test on Candidate Reference material as per requirements of IP- 2007 & USP
Calibration test as per requirements of IP-2007 & USP
Characterization test on Candidate Reference material as per requirements of IP- 2007 & USP
Calibration
Potency content
RP-HPLC
Characterization
Identification RP-HPLC Peptide map
Purity % related compounds RP-HPLC
% insulin aggregates SE-HPLC
Characterization
Identification RP-HPLC Peptide map
Purity % related compounds RP-HPLC
% insulin aggregates SE-HPLC
Lead Role of Collaborators
11
Work Progress in the study
1. NIB has received rh-insulin working Ref material from Four manufacturer's
2. Material received : i. powder and liquid formii. 4 vials or ampoules from each iii. Certificate information from 3 manufacturer
3. NIB has initiated Calibration using: i. Certified Ref material-NIBSC & USPii. Method –Potency , USP, EP as per Manufacturer CoA iii. Method –Potency -IP not given in Manufacturer’s CoA
12
S. No.
Logical order for presentation
Information required Information given by producer
Information given by highest metrological trace ability
1. The identity of the producer body and identification of the reference material
Name and address of certifying body √ √
2. Title of the document √ √
3. Name of the material √ √
4. Reference material code and batch number √ √
5.
A description of the material and its intended use
Description of the material, origin and history No √
6. Intended use No √
7. Instructions on the correct use of the material No √
8. Safety √
9. Level of homogeneity Partial √
10.
The certified values, their Traceability and the period of validity of the certificate
Certified values and their uncertainty intervals at a stated confidence level
Partial √
11. Traceability √ √
12. Values obtained by individual laboratories or methods √ √
13. Uncertified values √ √
14. Date of certification or assignment of property values √ √
15. Stability No √
16.
Other information
Further information √ √
17. Legal considerations Partial √
18. Signatures and names of certifying officer(s) or officer(s) signing an analysis certificate
√ √ & Leaflet
CERTIFICATE INFORMATION from rh-insulin Reference Material Producers
13
Recommending a Strategy
Ideas for Today and Tomorrow
Ideas for Today and Tomorrow
Outcome expected from the meeting g
Outcome Expected from the meeting
14
Recommending a Strategy
1 Time Lines Attached schedule to be agreed upon2 Label Text & Leaflet Draft to be reviewed & approved
3 rh-Insulin Candidate material Acceptance from 2-3 manufacturer’sMaterial for supply , filling & packing
4 Testing for Homogeneity Batch of Candidate Ref material a) intermediate checks b) checks in final packed form
5 Authorization of Property value to Reference Standard
By Technical competent body for Reference Standard
6
Distribution of designated Ref.Standard
Recommendation of Expert committee
7 Commercial cost of Ref Standard per vial or Ampoule
Cost to be proposed
15